Pfizer Buys Into Brazil
Pfizer has agreed to acquire a 40% stake in Brazilian genetic pharmaceutical company Laboratorio Teuto Brasileiro, with an option to take the rest starting in 2014. Pfizer will make an upfront...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.